Rajashekar Adurty, MD
Pulmonary Disease Physician · Pittsburgh, PA
Rajashekar Adurty, MD is a pulmonary disease physician with a practice address in Pittsburgh, Pennsylvania, and NPI 1659481570, issued on Aug 30, 2006. Check the license (Pennsylvania MD425045, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Rajashekar Adurty
- Credential
- MD
- Primary taxonomy
- Pulmonary Disease Physician 207RP1001X
- License number
- MD425045 PA
Self-reported in NPPES; status is on the state search - Practice location
- 490 East North Ave, Pittsburgh, PA 15212
- Phone
- (412) 322-7202
- Enumerated
- Aug 30, 2006
- Record last updated
- Oct 30, 2023
- Fax
- (412) 322-2144
- Medicaid IDs
- 1016954990001 PA
2745702 OH
3810008217 WV - Medicare enrollment
- Enrolled (PECOS I20060323000762); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest pulmonary disease physician records → All 779 in Pennsylvania → Look up another NPI →
Verify Rajashekar Adurty in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MD425045Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
98% more Medicare Part D claims than the average pulmonary disease physician in 2024
2,818 Medicare Part D claims for 394 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 54% of claims.
Most prescribed
- Trelegy Ellipta704 claims
- Montelukast Sodium301 claims
- Breo Ellipta243 claims
- Albuterol Sulfate Hfa211 claims
- Famotidine184 claims
- Anoro Ellipta126 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 93.8 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Bills Medicare through one group practice
- Allegheny ClinicPittsburgh, PA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Rajashekar Adurty among 779 pulmonary disease physician records in Pennsylvania
Rajashekar Adurty, MD is one of 779 pulmonary disease physician records with a practice address in Pennsylvania. 86% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 11% of them.
- NPI issued2006 · 11% of these records are older, 53% newer
- In a Medicare fileYes · 86% of these records are
- In the CMS Doctors and Clinicians fileYes · 73% of these records are
- Graduated1994 · median 2003 among the 568 with a school on file
- Record last updated2023 · 61% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RP1001X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Pulmonary Disease Physician providers in Pennsylvania
There are 779 pulmonary disease physician records in Pennsylvania.
All 779 in Pennsylvania → Every provider in Pittsburgh → Pulmonary Disease Physician nationwide →
The 8 pulmonary disease physician records with the nearest ZIP codes
- Ahmad Alhajhusain, MDPittsburgh, PA 152121932332780
- Hammad Arshad, MDPittsburgh, PA 152121407161862
- Omer Bajwa, MDPittsburgh, PA 152121073577391
- Tariq Cheema, MDPittsburgh, PA 152121134391840
- Aarthi Ganesh, MDPittsburgh, PA 152121386875854
- Peter Kaplan, MDPittsburgh, PA 152121538123856
- Khalid Malik, MDPittsburgh, PA 152121336100296
- Jennifer McCombPittsburgh, PA 152121205843448
Common questions
What is Rajashekar Adurty, MD's NPI number?
Rajashekar Adurty, MD's National Provider Identifier (NPI) is 1659481570, issued on Aug 30, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Rajashekar Adurty, MD located?
The NPPES record lists a practice address at 490 East North Ave, Pittsburgh, PA, 15212. Phone: (412) 322-7202. Providers update this record themselves, so call before visiting.
How can I verify Rajashekar Adurty, MD's license?
NPPES lists Pennsylvania license number MD425045, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Rajashekar Adurty, MD prescribe under Medicare Part D?
In 2024, Rajashekar Adurty, MD had 2,818 Medicare Part D claims for 394 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.
What is Rajashekar Adurty, MD's MIPS final score?
The 2023 MIPS final score is 93.8 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.